Cargando…
Multiple Sclerosis: Shall We Target CD33?
Background: Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS). Myeloid lineage cells (microglia and macrophages) may participate in the pathogenic mechanisms leading to MS. CD33 is a transmembrane receptor, mainly expressed by myeloid lineage cells. CD33 rs3865444 is a...
Autores principales: | Siokas, Vasileios, Tsouris, Zisis, Aloizou, Athina-Maria, Bakirtzis, Christos, Liampas, Ioannis, Koutsis, Georgios, Anagnostouli, Maria, Bogdanos, Dimitrios P., Grigoriadis, Nikolaos, Hadjigeorgiou, Georgios M., Dardiotis, Efthimios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696272/ https://www.ncbi.nlm.nih.gov/pubmed/33198164 http://dx.doi.org/10.3390/genes11111334 |
Ejemplares similares
-
Anti-MOG Positive Bilateral Optic Neuritis and Brainstem Encephalitis Secondary to COVID-19 Infection: A Case Report
por: Tsouris, Zisis, et al.
Publicado: (2022) -
MOBP rs616147 Polymorphism and Risk of Amyotrophic Lateral Sclerosis in a Greek Population: A Case-Control Study
por: Liampas, Ioannis, et al.
Publicado: (2021) -
Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options
por: Andravizou, Athina, et al.
Publicado: (2019) -
Genetic Risk Factors for Essential Tremor: A Review
por: Siokas, Vasileios, et al.
Publicado: (2020) -
ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease
por: Siokas, Vasileios, et al.
Publicado: (2021)